AJ302-IM for Healthy Volunteers
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications, but it mentions the use of medications for certain timeframes specified in the protocol. It's best to discuss your current medications with the trial coordinators.
What safety data exists for AJ302-IM or similar treatments in healthy volunteers?
The safety of healthy volunteers in clinical trials is generally well-monitored, with minor adverse effects reported in a small percentage of participants. In a survey, minor adverse effects were reported in about 6.9% of healthy volunteers, with no lasting harm. This suggests that the risk involved in such studies is very small.12345
How is the drug AJ302-IM different from other treatments for autoimmune myopathy?
The research does not provide specific information about AJ302-IM, but it suggests that autoimmune myopathies involve complex immune responses, including T-helper cell activity. AJ302-IM may target these immune pathways differently than existing treatments, potentially offering a novel approach to managing the condition.678910
What is the purpose of this trial?
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AJ302-IM following intramuscular administration of single ascending doses in healthy volunteers.
Eligibility Criteria
This clinical trial is for healthy volunteers who want to help test a new medication. There are specific requirements and exclusions that aren't listed here, but generally, participants should be in good health without any major medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive single ascending doses of AJ302-IM via intramuscular injection
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- AJ302-IM
Find a Clinic Near You
Who Is Running the Clinical Trial?
AnnJi Pharmaceutical Co., Ltd.
Lead Sponsor